Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projekte/946-a-phase-ii-open-label-study-to-investigate-the-efficacy-and-safety-of-domatinostat-in-combination-with-avelumab-in-patients-with-advanced-unresectablemetastatic-merkel-cell-carcinoma-progressing-on-anti-pd-l1-antibody-therapy-the-merklin-2-study